Analysts Set ALX Oncology Holdings Inc. (NASDAQ:ALXO) Target Price at $3.30

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six brokerages that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price […]

Leave a Reply

Your email address will not be published.

Previous post DA Davidson Brokers Boost Earnings Estimates for Ulta Beauty
Next post Motorola Solutions, Inc. (NYSE:MSI) Receives $515.44 Consensus PT from Analysts